These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 19389395)

  • 1. alpha(2)-Adrenoceptor agonist xylazine induces peripheral antinociceptive effect by activation of the L-arginine/nitric oxide/cyclic GMP pathway in rat.
    Romero TR; Duarte ID
    Eur J Pharmacol; 2009 Jun; 613(1-3):64-7. PubMed ID: 19389395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ketamine activates the L-arginine/Nitric oxide/cyclic guanosine monophosphate pathway to induce peripheral antinociception in rats.
    Romero TR; Galdino GS; Silva GC; Resende LC; Perez AC; Côrtes SF; Duarte ID
    Anesth Analg; 2011 Nov; 113(5):1254-9. PubMed ID: 21788321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tingenone, a pentacyclic triterpene, induces peripheral antinociception due to NO/cGMP and ATP-sensitive K(+) channels pathway activation in mice.
    de Carvalho Veloso C; Rodrigues VG; Ferreira RC; Duarte LP; Klein A; Duarte ID; Romero TR; de Castro Perez A
    Eur J Pharmacol; 2015 May; 755():1-5. PubMed ID: 25748602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noradrenaline activates the NO/cGMP/ATP-sensitive K(+) channels pathway to induce peripheral antinociception in rats.
    Romero TR; Guzzo LS; Perez AC; Klein A; Duarte ID
    Nitric Oxide; 2012 Mar; 26(3):157-61. PubMed ID: 22330728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The kappa-opioid agonist (+/-)-bremazocine elicits peripheral antinociception by activation of the L-arginine/nitric oxide/cyclic GMP pathway.
    Amarante LH; Duarte ID
    Eur J Pharmacol; 2002 Nov; 454(1):19-23. PubMed ID: 12409000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of the L-arginine/nitric oxide/cyclic guanosine monophosphate pathway in peripheral antinociception induced by N-palmitoyl-ethanolamine in rats.
    Romero TR; Galdino GS; Silva GC; Resende LC; Perez AC; Cortes SF; Duarte ID
    J Neurosci Res; 2012 Jul; 90(7):1474-9. PubMed ID: 22411529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ang-(1-7) activates the NO/cGMP and ATP-sensitive K+ channels pathway to induce peripheral antinociception in rats.
    Costa A; Galdino G; Romero T; Silva G; Cortes S; Santos R; Duarte I
    Nitric Oxide; 2014 Feb; 37():11-6. PubMed ID: 24361899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. delta-Opioid receptor agonist SNC80 elicits peripheral antinociception via delta(1) and delta(2) receptors and activation of the l-arginine/nitric oxide/cyclic GMP pathway.
    Pacheco DF; Reis GM; Francischi JN; Castro MS; Perez AC; Duarte ID
    Life Sci; 2005 Nov; 78(1):54-60. PubMed ID: 16135369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probable involvement of alpha(2C)-adrenoceptor subtype and endogenous opioid peptides in the peripheral antinociceptive effect induced by xylazine.
    Romero TR; de Castro Perez A; de Francischi JN; Gama Duarte ID
    Eur J Pharmacol; 2009 Apr; 608(1-3):23-7. PubMed ID: 19236861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of ATP-sensitive K(+) channels in the peripheral antinociceptive effect induced by the alpha(2)-adrenoceptor agonist xylazine.
    Romero TR; Duarte ID
    J Pharmacol Sci; 2009 Dec; 111(4):323-7. PubMed ID: 20019444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NO/cGMP production is important for the endogenous peripheral control of hyperalgesia during inflammation.
    Alves DP; da Motta PG; Romero TR; Klein A; Duarte ID
    Nitric Oxide; 2013 Jan; 28():8-13. PubMed ID: 22995857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of the L-arginine/Nitric Oxide/Cyclic GMP/KATP Channel Pathway and PPARγ Receptors in the Peripheral Antinociceptive Effect of Carbamazepine.
    Ghorbanzadeh B; Kheirandish V; Mansouri MT
    Drug Res (Stuttg); 2019 Dec; 69(12):650-657. PubMed ID: 31272117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. L-NAME causes antinociception by stimulation of the arginine-NO-cGMP pathway.
    Duarte ID; Ferreira SH
    Mediators Inflamm; 2000; 9(1):25-30. PubMed ID: 10877451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of L-arginine/NO/cGMP/K(ATP) channel pathway in the peripheral antinociceptive actions of ellagic acid in the rat formalin test.
    Ghorbanzadeh B; Mansouri MT; Hemmati AA; Naghizadeh B; Mard SA; Rezaie A
    Pharmacol Biochem Behav; 2014 Nov; 126():116-21. PubMed ID: 25278343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opioid receptor and NO/cGMP pathway as a mechanism of peripheral antinociceptive action of the cannabinoid receptor agonist anandamide.
    Reis GM; Pacheco D; Perez AC; Klein A; Ramos MA; Duarte ID
    Life Sci; 2009 Aug; 85(9-10):351-6. PubMed ID: 19576231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnesium sulphate activates the L-arginine/NO/cGMP pathway to induce peripheral antinociception in mice.
    Teixeira LRM; Castro Perez A; Lima Romero TR; Gama Duarte ID
    Magnes Res; 2022 Jan; 35(1):1-10. PubMed ID: 36214549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrathecally injected morphine inhibits inflammatory paw edema: the involvement of nitric oxide and cyclic-guanosine monophosphate.
    Brock SC; Tonussi CR
    Anesth Analg; 2008 Mar; 106(3):965-71, table of contents. PubMed ID: 18292447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction in [D-Ala2, NMePhe4, Gly-ol5]enkephalin-induced peripheral antinociception in diabetic rats: the role of the L-arginine/nitric oxide/cyclic guanosine monophosphate pathway.
    Tasatargil A; Sadan G
    Anesth Analg; 2004 Jan; 98(1):185-192. PubMed ID: 14693616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The synthetic peptide PnPP-19 induces peripheral antinociception via activation of NO/cGMP/K
    Freitas AC; Silva GC; Pacheco DF; Pimenta AM; Lemos VS; Duarte ID; de Lima ME
    Nitric Oxide; 2017 Apr; 64():31-38. PubMed ID: 28087360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Additive antinociceptive effect of the combination of diazoxide, an activator of ATP-sensitive K+ channels, and sodium nitroprusside and dibutyryl-cGMP.
    Alves DP; Soares AC; Francischi JN; Castro MS; Perez AC; Duarte ID
    Eur J Pharmacol; 2004 Apr; 489(1-2):59-65. PubMed ID: 15063156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.